Sirius Genomics

Vancouver, Canada-based Sirius Genomics is using arrays to develop a test to identify individuals who respond to the hormone vasopressin and similar compounds for the treatment of septic shock.

The two firms will partner to develop diagnostics to identify individuals who respond well to Vasopressin and other compounds for the treatment of septic shock and related conditions.

In Brief This Week is a Friday column containing news items that our readers may have missed during the week.

Pairings

Premium

Kamran Alam, Stan Lapidus

Pairings

Premium

Chris Wagner, Brad Popovich, Jorge Garces, Greg Hamilton, Nick Williams, Darren Hall

In Brief This Week is a Friday column containing news items that our readers may have missed during the week.

Sirius will work with a system of 37 hospitals to test biomarkers for severe sepsis drug response.

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.